Intravenous Infusions Plc reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was GHS 31.39 million compared to GHS 20.39 million a year ago. Net income was GHS 5.06 million compared to net loss of GHS 3.27 million a year ago.

Basic earnings per share from continuing operations was GHS 0.018 compared to basic loss per share from continuing operations of GHS 0.012 a year ago.